Technical Analysis for ACAD - ACADIA Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 37.59 -0.11% -0.04
ACAD closed down 0.11 percent on Friday, September 22, 2017, on 62 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ACAD trend table...

Date Alert Name Type % Chg
Sep 22 Stochastic Reached Overbought Other 0.00%
Sep 19 MACD Bearish Signal Line Cross Bearish 2.85%
Sep 15 Golden Cross Bullish 2.06%
Sep 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.06%
Sep 14 NR7 Range Contraction 3.35%

Older signals for ACAD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by pimavanserin, which is in Phase III development stage for the treatment of Parkinson's disease psychosis. It is also developing pimavanserin that has completed Phase II co-therapy trials for the treatment of schizophrenia; and is in Phase II clinical trials for the treatment of Alzheimer's disease psychosis. In addition, the company, through collaboration with Allergan, Inc., is developing alpha adrenergic agonists, which are in Phase II clinical trials for the treatment of chronic pain; and muscarinic agonist that is in Phase I clinical trials for the treatment of glaucoma. Further, it is developing two advanced preclinical programs directed at Parkinson's disease and other neurological disorders. The company was formerly known as Receptor Technologies, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Is ACAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 40.83
52 Week Low 20.68
Average Volume 1,388,523
200-Day Moving Average 31.9435
50-Day Moving Average 32.6806
20-Day Moving Average 35.971
10-Day Moving Average 36.951
Average True Range 1.0927
ADX 26.45
+DI 27.04
-DI: 13.52
Chandelier Exit (Long, 3 ATRs) 34.7519
Chandelier Exit (Short, 3 ATRs) 34.4181
Upper Bollinger Band 38.7172
Lower Bollinger Band 33.2248
Percent B (%b) 0.79
Bandwidth 0.15269
MACD Line 1.4033
MACD Signal Line 1.4563
MACD Histogram -0.053